Dr. Sheldon Brookman, is President of Clinical Decisions LLC, a consulting company providing clinical and regulatory development strategies. Sheldon has over 25 years of clinical and product development experience in the pharmaceutical industry and has held executive level development and regulatory positions with several pharmaceutical companies and CROs. He has designed and conducted more than four dozen Phase I through IV trials and has filed numerous regulatory submissions in the United States, Canada and South America. He was trained in Industrial Pharmacy at the University of Montreal, where he graduated with honors. Dr. Brookman also holds a PhD in Experimental Medicine and Surgery from the University of Montreal.